• HSD88 A Practical Approach for the Adoption of the Hub and Spoke Model for Cell and Gene Therapies in Low- and Middle-Income Countries: Framework and Simulation Case Studies

    Jun 1, 2023, 00:00

  • HSD31 Real-World Pediatric Oncologist Utilization and Perceptions of Next Generation Sequencing

    Jun 1, 2023, 00:00

  • EE350 Cost-Effectiveness of Mirogabalin in Treatment of Diabetic Peripheral Neuropathic Pain in Mainland China

    Jun 1, 2023, 00:00

  • PCR109 Health State Utilities Associated with Weight Loss in People with Type 2 Diabetes in Japan

    Jun 1, 2023, 00:00

  • HTA77 Training and Active Social Participation in the Incorporation of Health Technologies in the Brazilian Unified Health System

    Jun 1, 2023, 00:00

  • EE200 Simple Approach for Developing Parametric Survival Based Cost-Effectiveness Analysis (CEA): Case Study of Heart Failure with Reduced Ejection Fraction (HFREF)

    Jun 1, 2023, 00:00

  • EE287 Healthcare Resource Utilization Among Patients with Transfusion-Dependent Beta-Thalassemia in England

    Jun 1, 2023, 00:00

  • One-Year Temporal Changes in Long COVID Prevalence and Characteristics: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • PCR137 Evaluation of Digital Health Solutions from Two Large Dermatology Epidemiological Studies

    Jun 1, 2023, 00:00

  • EPH253 Clinical Profile of Patients Treated with CGRP mAbs: An Evaluation of Proximate Migraine Diagnosis

    Jun 1, 2023, 00:00

  • PCR184 Impact of COVID-19 Symptoms on Patients' Health-Related Quality of Life

    Jun 1, 2023, 00:00

  • CO99 Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes

    Jun 1, 2023, 00:00

  • EE242 The Economic Impact of Antimicrobial Stewardship Program in the Adults’ General Medicine Setting in Qatar

    Jun 1, 2023, 00:00

  • HPR80 Biosimilars Policy Framework for the Private Sector in the United Arab Emirates

    Jun 1, 2023, 00:00

  • EPH104 Overview of the Healthcare Systems of the Maghreb Countries: Issues and Progress

    Jun 1, 2023, 00:00

  • CO134 The Future of COVID-19: What Is Next in the Drug Pipeline

    Jun 1, 2023, 00:00

  • CO119 Clinical Utility of Circulating Tumor Cell Enumeration-Based Liquid Biopsy in Patients with Metastatic Breast Cancer: A Review of the Peer-Reviewed Clinical Literature

    Jun 1, 2023, 00:00

  • EPH147 Trajectories of Sacubitril/Valsartan Adherence Among Medicare Beneficiaries with Heart Failure

    Jun 1, 2023, 00:00

  • EE492 Costs of Illness Associated with Relapses in Neuromyelitis Optica Spectrum Disorder: An Administrative Claims Database Analysis

    Jun 1, 2023, 00:00

  • MSR80 A Dynamic Panel Binary Data Model for Personalized Patient Engagement Prediction

    Jun 1, 2023, 00:00

  • EE218 The Wave of the Future? Alternative Digital Value Communication Solutions to Enhance Engagements between US Payers and MSLs

    Jun 1, 2023, 00:00

  • EPH121 Predictors of Persistent Opioid Use in Non-Cancer Older Adults

    Jun 1, 2023, 00:00

  • EPH183 Impact of a Cancer Diagnosis on Non-Cancer Chronic Disease Medication Adherence - A Systematic Literature Review

    Jun 1, 2023, 00:00

  • Real-World Data Information Systems

    Jun 1, 2023, 00:00

  • EE420 Contamination Rate and Economic Evaluation for Repeated Use of Medicated Preservative-Free Unit-Dose Eye Drops

    Jun 1, 2023, 00:00

  • EE340 Integrating Real-World Evidence in Economic Evaluation of Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation in a Developing Country

    Jun 1, 2023, 00:00

  • HSD106 Trends in Second Generation Antipsychotic Prescribing for Adolescents from 2013-2021

    Jun 1, 2023, 00:00

  • HTA19 Is NICE Becoming Less ‘NICE’? a Time-Trend Analysis

    Jun 1, 2023, 00:00

  • EE166 Cost-Effectiveness of Alpelisib Plus Fulvestrant in Postmenopausal Women with Hr+/HER2- Advanced Breast Cancer (ABC) in Qatar

    Jun 1, 2023, 00:00

  • EE71 Budget Impact Analysis of a Non-Invasive Temperature-Controlled Radiofrequency Device for the Treatment of Nasal Airway Obstruction

    Jun 1, 2023, 00:00

  • EE462 The Financial Impact of Closing the Diabetes Hemoglobin HBA1C Care Gap at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2023, 00:00

  • EE425 Impact of Inclusion of Finerenone in the Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia

    Jun 1, 2023, 00:00

  • EPH16 Opioid-Related Overdose Deaths in the South Region of the U.S. from 2013 to 2020

    Jun 1, 2023, 00:00

  • PCR197 Right Member, Right Time, Right Care: Evaluating Blue Cross and Blue Shield of Louisiana’s Impactability Score

    Jun 1, 2023, 00:00

  • EE38 Budget Impact of a Blood-Based Integrated Classifier Test to Down Classify Risk of Pulmonary Nodules in a US Medicare Payer Setting

    Jun 1, 2023, 00:00

  • HTA104 A Multicriteria Decision Analysis - Proposal of Evaluation Criteria for Treatments of Rare Diseases in Brazil

    Jun 1, 2023, 00:00

  • CO205 Evaluating Disease-Free Survival (DFS) As a Surrogate Endpoint (SE) for Overall Survival (OS) in Muscle-Invasive Urothelial Carcinoma (MIUC): An Analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare Data

    Jun 1, 2023, 00:00

  • EE207 Productivity Benefits from Introducing ID Now™ Influenza into a Company's Medical Clinic for Influenza Diagnosis

    Jun 1, 2023, 00:00

  • MSR79 Predicting Medication Adherence Using Blue Cross and Blue Shield of Louisiana's Historical Medical Claims

    Jun 1, 2023, 00:00

  • CO219 Effect of Smoking Cessation (SC) Interventions Among People with Lung Cancer (LC): A Systematic Literature Review

    Jun 1, 2023, 00:00

  • EE453 Baseline Cognitive Performance Is a Determinant of Prospective Health Resource Utilization Among Adults with Chronic Stroke: A Secondary Analysis

    Jun 1, 2023, 00:00

  • RWD32 Oxidized Zirconium Results in Significantly Reduced Readmissions and Mortality for Patients Undergoing Hip Arthroplasty Due to Hip Fracture

    Jun 1, 2023, 00:00

  • EPH217 Real-World Trends in Hospitalizations for Hepatic Encephalopathy and Associated Costs Among Adults in the United States

    Jun 1, 2023, 00:00

  • RWD150 Cost of Illness: Estimating Direct Healthcare Costs Related to Obesity in a Japanese Clinical Setting

    Jun 1, 2023, 00:00

  • EPH189 Assessment of Burden of COVID-19 Infection and the Dynamics in African Union Member States

    Jun 1, 2023, 00:00

  • RWD47 Relationship Between Self-Reported Mental Health and Characteristics of US Adults Age ≥50 Years with Self-Reported Pain and Documented Opioid Treatment

    Jun 1, 2023, 00:00

  • HSD48 Medication Titration and Outpatient Appointment Requirements for Heart Failure Patients with Reduced Ejection Fraction in Ireland

    Jun 1, 2023, 00:00

  • PCR100 Development and Validation of Patient-Reported Outcome Measures for Platysma Prominence

    Jun 1, 2023, 00:00

  • RWD4 Developing a Risk Prediction Model for Heart Failure (HF) Incidence in Patients with Diabetes Mellitus Using AI Ml Techniques

    Jun 1, 2023, 00:00

  • EE59 Development and Validation of the Natural History Component of an Economic Model for Primary Sclerosing Cholangitis

    Jun 1, 2023, 00:00

  • EPH154 Assessing Impact of the Affordable Care Act on Measles-Mumps-Rubella (MMR) Vaccination Rates Using the National Ambulatory Medical Care Survey

    Jun 1, 2023, 00:00

  • EE437 Economic Value of Covered Expanded Polytetrafluoroethylene (EPTFE) Stent Grafts Compared to Percutaneous Balloon Angioplasty for Treating Thrombosed and Dysfunctional Arteriovenous Grafts in Hemodialysis Patients in Germany

    Jun 1, 2023, 00:00

  • EE573 Cost-Effectiveness of Innovative Treatments of HER2+ Breast Cancer in Peru

    Jun 1, 2023, 00:00

  • EE571 The Size Paradox: Comprehensive Data and Better Methods Can Yield Significant Results with Smaller Sample Sizes in Real World Data (Size Doesn't Always Matter)

    Jun 1, 2023, 00:00

  • RWD28 Patient Characteristics and Social Determinants of Health in a Large Real-World Cohort of Vitiligo Patients in the U.S.

    Jun 1, 2023, 00:00

  • EE496 Comparative Healthcare Burden for Colorectal Cancer and Other Cancers: Medical Expenditure Panel Survey Study

    Jun 1, 2023, 00:00

  • RWD49 Burden of Hospitalizations in Amyotrophic Lateral Sclerosis (ALS): Comparison of Medicare and Private Payer Populations

    Jun 1, 2023, 00:00

  • CO73 Patient Characteristics, Treatment Patterns, and Factors of Biomarker Testing Among Patients with Advanced Non-Small Cell Lung Cancer (ANSCLC) in the US, 2012-2020

    Jun 1, 2023, 00:00

  • Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs

    Jun 1, 2023, 00:00

  • EE117 How Expensive Is Arterial Hypertension in a Colombian Insurance Company?

    Jun 1, 2023, 00:00

  • HTA51 Impact of ICER Assessments on Payer Decision Making in the United States

    Jun 1, 2023, 00:00

  • EPH52 Healthcare Utilization Among Medicare Fee-for-Service (FFS) Beneficiaries in 2019 By Historically Redlined Status of Place of Residence

    Jun 1, 2023, 00:00

  • HSD76 Investigating the Impact of Self-Help Groups on Opioid Use Disorder Treatment Retention

    Jun 1, 2023, 00:00

  • MSR78 Knowledgesphere: An Automated and Integrative Framework for Drug Repurposing Empowered By Knowledge Graph and AI

    Jun 1, 2023, 00:00

  • MSR52 Identifying Adult Patients with Non-Relapsing Secondary Progressive Multiple Sclerosis Using Algorithms in US-Based Healthcare Databases

    Jun 1, 2023, 00:00

  • CO2 Evaluation of Clinical Decision Support to Improve Care for Patients with Atrial Fibrillation at Increased Stroke Risk: 2-Year Results

    Jun 1, 2023, 00:00

  • EPH203 Patients Characteristics, Vaccine Uptake, Healthcare Resource Utilization and Costs Associated with Acute COVID-19 during the Omicron Predominant Period in Brazil: A Nationwide Database Study

    Jun 1, 2023, 00:00

  • HPR74 How the Influence of Pathways of Care Differs By Site of Care in the United States

    Jun 1, 2023, 00:00

  • CO173 Quality of Life and Cost of Protraction or Orthognathic Surgery for Class III Malocclusion in Patients with Cleft Lip and Palate

    Jun 1, 2023, 00:00

  • PCR9 Health Care Use and Out-of-Pocket Costs after a Transitional Palliative Care Intervention for Rural Family Caregivers and Care Recipients: A Randomized Controlled Trial

    Jun 1, 2023, 00:00

  • EE435 Value for Money of Post-Market Surveillance of Medicines: Evidence from Indonesia

    Jun 1, 2023, 00:00

  • MT51 Increased Real-World Biomarker Test Utilization in Patients with Early-Stage Non-Small Cell Lung Cancer in the United States, 2011 to 2021

    Jun 1, 2023, 00:00

  • EE475 Eradication of Helicobacter Pylori with Vonoprazan-Bismuth Containing Quadruple Therapy in China: A Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • EPH50 Impact of COVID-19 on the Change in Work Conditions and Career Choices in General Vietnamese Population

    Jun 1, 2023, 00:00

  • PCR169 A Systematic Literature Review (SLR) of Health State Utility Values (HSUV) in Metastatic Castration-Resistant Prostate Cancer (MCRPC)

    Jun 1, 2023, 00:00

  • EE256 Comparative Cost-Utility Analysis of Galcanezumab and Fremanezumab for Migraine Prevention in Individuals with Chronic Migraine Who Have Tried 2 to 4 Prior Preventive Treatments

    Jun 1, 2023, 00:00

  • HSD32 Are We ‘Choosing Wisely’? Use of Surveillance Advanced Imaging and Serum Tumor Biomarker Testing in Older Women with Breast Cancer

    Jun 1, 2023, 00:00

  • RWD164 Real-World Prevalence of Genetic Mutations in Female Breast Cancer Patients Aged 65 Vs. >=65 Years in the US between 2014 and 2022

    Jun 1, 2023, 00:00

  • EE246 Cognitive Behavioral Therapy (CBT) Vs. Oral Antidepressants for Treatment of Depression in Older Adults: A Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • CO161 Evaluation of Surrogate Endpoints for Overall Survival in Platinum-Resistant/Refractory Ovarian Cancer

    Jun 1, 2023, 00:00

  • PCR208 Patient Preferences for Long-Acting Antiretroviral Therapy Among Patients Living with HIV in Kenya: Results from a Pilot Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • HPR30 Review of Indication-Based Pricing Practice in Switzerland

    Jun 1, 2023, 00:00

  • RWD42 Racial Disparities in Clinical Outcomes and Treatment Pattern to Chronic Diseases in the US: A Real World Study Based on Administrative Claims and Electronic Health Records Data

    Jun 1, 2023, 00:00

  • EE403 Direct and Indirect Costs Among Employed Patients with Myasthenia Gravis in Sweden

    Jun 1, 2023, 00:00

  • PCR61 Persistent Work Limitations in Long COVID: A Cross-Sectional Analysis of Employed US Respondents to the 2022 National Health and Wellness Survey

    Jun 1, 2023, 00:00

  • CO49 Comparative Efficacy of Pharmacological Therapies for Heart Failure with Reduced Ejection Fraction: A Network Meta-Analysis of Randomized Controlled Trials

    Jun 1, 2023, 00:00

  • CO60 Maternal Mental Health Disorders May Increase Odds of Adverse Intrauterine and Birth Outcomes

    Jun 1, 2023, 00:00

  • CO84 Real-World Assessment of All-Cause and Cardiovascular-Related Inpatient Readmissions, Healthcare Resource Utilization, and Costs Among Type 2 Diabetes Patients with and without Chronic Kidney Disease

    Jun 1, 2023, 00:00

  • Cover

    Jun 1, 2023, 00:00

  • MSR69 Leading Predictors of Economic Burden Among Postmenopausal Women with Heart Failure: An Application of Machine Learning with Xgboost and Shapley Additive Explanations

    Jun 1, 2023, 00:00

  • CO109 Patient-Reported Improvements in “Off”-Time Quality, Non-Motor Fluctuation Severity, and Medication Satisfaction in the Real-World Opti-on Study of Opicapone in Parkinson’s Disease

    Jun 1, 2023, 00:00

  • EE271 Economic Evaluation (EE) of Cervical Cancer Screening Methods in Unites States: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • RWD53 Assessing the Association of Various Characteristics with Perceived Health Status Among Adults with Skin Cancer in the United States

    Jun 1, 2023, 00:00

  • EPH238 Head and Neck Squamous Cell Carcinoma Epidemiology at Diagnosis: A Description of Public and Private Health Care Systems in Brazil Regarding Tumor Location, Staging, Risk Factors and Mortality

    Jun 1, 2023, 00:00

  • EE471 Cost-Effectiveness Evaluation of Human Papilloma Virus Test in Comparison with Cytology in Costa Rica from the Public Health System Perspective

    Jun 1, 2023, 00:00

  • Cross-Attribute Level Effects Models for Modeling Modified 5-Level Version of EQ-5D Health State Values: Is Less Still More?

    Jun 1, 2023, 00:00

  • HSD111 Prescription Opioid Use Among Cancer Patients before and after the Onset of COVID-19: Evidence from Real-World Data

    Jun 1, 2023, 00:00

  • EE458 Economic Evaluation of Lifestyle Interventions to Promote Cognition in Older Adults with Chronic Stroke

    Jun 1, 2023, 00:00

  • EPH261 How Does Private Health Insurance Supplement Public Health Insurance and Encourage Preventive Care Usage?: A Longitudinal Study in Australia

    Jun 1, 2023, 00:00

  • RWD109 The Use of Real-World Evidence in FDA Regulatory Submissions: A Review

    Jun 1, 2023, 00:00

  • CO230 Efficacy and Safety of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus

    Jun 1, 2023, 00:00

  • RWD149 Real-World Comparison of Cardiovascular Benefits between Sodium-Glucose Cotransporter 2 (SGLT-2I) and Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) Inhibitors in Patients with Type 2 Diabetes (T2D)

    Jun 1, 2023, 00:00

  • HTA102 Early Scientific Advice in Europe: An Overview of Processes and Requirements

    Jun 1, 2023, 00:00

  • PCR223 Real-World Observational Study of Mogamulizumab in Adult Patients with Mycosis Fungoides and Sézary Syndrome (PROSPER)

    Jun 1, 2023, 00:00

  • MSR61 AI Support Reduced Screening Burden in a Systematic Review with Costs and Cost-Effectiveness Outcomes (SR-CCEO) for Cost-Effectiveness Modeling

    Jun 1, 2023, 00:00

  • CO213 Combination of Targeted Therapy with Chemotherapy (T+C) Versus Chemotherapy Alone (C) As a First Line (1L) Treatment in Patients with Esophageal Squamous Cell Carcinoma (ESCC): A Systematic Literature Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • HPR10 The Desirability of Implementing an Outcome-Based Delayed Payment Model for Autologous Gene Therapy Atidarsagene Autotemcel (LIBMELDY®)

    Jun 1, 2023, 00:00

  • PCR79 Unmet Needs in Therapeutic Trajectories of Adult Patients Living with Lung Cancer in Chile: A Qualitative Case Study

    Jun 1, 2023, 00:00

  • EE110 Costs and Resource Utilization of People with Stable Heart Failure and Insomnia: Evidence from a Randomized Trial

    Jun 1, 2023, 00:00

  • HTA4 Pembrolizumab Vs. Standard of Care Chemotherapy As First-Line Treatment for Advanced Non-Small Cell Lung Cancer with High Pd-L1 Expression Levels: A Cost-Utility Analysis from the Ontario, Canada Public Payer Perspective

    Jun 1, 2023, 00:00

  • HTA57 Quantifying Heterogeneity within and between Treatment Guidelines for Type 2 Diabetes: Potential Implications for EU-Wide Health Technology Assessment

    Jun 1, 2023, 00:00

  • HPR95 Inflation Reduction Act: Assessing the Impact for New Drug Development, Launch, Life Cycle Management and Loss of Exclusivity

    Jun 1, 2023, 00:00

  • EE85 A Cost-Utility Analysis Comparing a Clinical Decision Support Software to Prescriber Decision Alone for Drug-Drug Interactions from an U.S. Payer Perspective

    Jun 1, 2023, 00:00

  • CO153 Examining Time to All-Cause Hospitalization or Death Among Second-Generation Antipsychotics Long-Acting Injectables in Schizophrenia

    Jun 1, 2023, 00:00

  • SA46 Understanding the Complexities of the Israeli Mytrial Registry

    Jun 1, 2023, 00:00

  • PCR69 Change in the Rates of Non-Adherence with Migraine Medicines in the United States between 2019 and 2021 Using the Medication Adherence Reasons Scale

    Jun 1, 2023, 00:00

  • EE364 Medical Care Costs of Veterans with Spinal Cord Injury Prescribed a Personal Use Powered Exoskeleton

    Jun 1, 2023, 00:00

  • HTA70 Use of Economic Evaluation of Vaccines: The Experience in Colombia, 2000 to 2021

    Jun 1, 2023, 00:00

  • PCR58 Comparing Adherence in Patients with Type 2 Diabetes Initiating Glucagon-like Peptide-1 Receptor Agonists or Sodium-Glucose Cotransporter-2 Inhibitors

    Jun 1, 2023, 00:00

  • HPR117 Cross-Category Competition in Chinese Basic Medical Insurance Drug Formulary

    Jun 1, 2023, 00:00

  • EE91 Cost-Effectiveness Analysis of Differential Target MULTIPLEXEDTM Spinal Cord Stimulation in Sweden

    Jun 1, 2023, 00:00

  • PCR102 Relationship between Health-State Utility Values, Self-Efficacy, and Health Locus of Control in the General Population

    Jun 1, 2023, 00:00

  • HPR62 Making the Cut: An Assessment of ICER’s Acceptance of Evidence in Unsupported Price Increase Reports

    Jun 1, 2023, 00:00

  • HSD6 Unnecessary Staging Imaging in Patients with Early Stage Breast Cancer Varies By Cancer Stage: Are We Choosing Wisely?

    Jun 1, 2023, 00:00

  • EPH55 Adherence and Persistence with SGLT-2 Inhibitors Among White and Black Diabetic Kidney Disease Patients: Real-World Evidence from a Large US Claims Database

    Jun 1, 2023, 00:00

  • HPR68 Inflation Reduction Act – Insights and Impact on Different Therapeutic Areas from the US Commercial Payer Perspective

    Jun 1, 2023, 00:00

  • HSD47 Predictors of Initial Antihypertensive Intensity in Newly-Treated Hypertension Patients with Hypertension

    Jun 1, 2023, 00:00

  • RWD131 Treatment Patterns, Healthcare Resource Utilization (HCRU), and Direct Costs for Bacterial Vaginosis (BV) in US Commercially Insured Populations

    Jun 1, 2023, 00:00

  • RWD85 Association between Relative Risk of Dementia and Baseline Visual Impairment Along with Other Confounding Features

    Jun 1, 2023, 00:00

  • Disclaimer

    Jun 1, 2023, 00:00

  • PCR163 Work Productivity Impairment Among Individuals with Progressive Multiple Sclerosis

    Jun 1, 2023, 00:00

  • RWD81 Long-Term Metabolic Sequelae of COVID-19, By Severity Levels

    Jun 1, 2023, 00:00

  • EE521 Healthcare Costs Associated with Liver Transplantation in Young Patients: A Population-Based Retrospective Cohort Study in Korea

    Jun 1, 2023, 00:00

  • EPH24 Gender and Racial Disparities and All-Cause Mortality in Bladder Cancer Patients in the U.S.

    Jun 1, 2023, 00:00

  • MSR63 Analysis of Rare Events in Outcomes Research Using Department of Defense Data: Intravenous Immune Globulin Therapy for Bulluous Pemphiogoid

    Jun 1, 2023, 00:00

  • MT18 Effectiveness, Safety and Economic Evaluation of Using Varied-Height Surgical Staplers in Laparoscopic Hepatectomy for Liver Cancer: A Retrospective, Real-World Study

    Jun 1, 2023, 00:00

  • RWD9 Healthcare Related Costs with Biological Therapy in Patients with Axial Spondyloarthritis (AXSPA): Real World Evidence from a Tertiary Hospital from Bogota, Colombia

    Jun 1, 2023, 00:00

  • MSR68 Bridging the Gap in Disconnected Networks in Network Meta-Analysis (NMA)

    Jun 1, 2023, 00:00

  • MT7 Hospital Waste and Cost Prevention Potential of Reprocessing Medical Devices

    Jun 1, 2023, 00:00

  • MSR11 A Multi-Method Approach to an Indirect Treatment Comparison of Eplontersen and Vutrisiran for the Treatment of Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

    Jun 1, 2023, 00:00

  • EE479 Conditionally Essential Amino Acids Can Reduce the Economic Burden of Postoperative Complications after Fracture Fixation: Results from an Economic Model

    Jun 1, 2023, 00:00

  • CO184 US Population Burden of Acute Heart Failure Events and Hospitalization in Patients with Recent Worsening Heart Failure and Left Ventricular Ejection Fraction ≤30%

    Jun 1, 2023, 00:00

  • EPH35 Comorbidities in Elderly Patients with Oral Corticosteroid-Dependent Asthma in South Korea

    Jun 1, 2023, 00:00

  • PCR65 Psychometric Assessment of the Psoriatic Arthritis Impact of Disease-12 (PsAID-12) Questionnaire Using Pooled Data from the Phase 3 BE OPTIMAL and BE COMPLETE Trials of Bimekizumab in Patients with Psoriatic Arthritis

    Jun 1, 2023, 00:00

  • EPH244 Risk Stratification and Predictive Modeling of Acute Asthma Exacerbations Using Real World Data of All Payers Claims Data in the US

    Jun 1, 2023, 00:00

  • HTA30 The NICE Vs SMC Cost Comparison Pathways – How Similar Are They?

    Jun 1, 2023, 00:00

  • EE120 Assessing the Potential Cost Effectiveness of Cell Therapy Adjuvant to Surgery for Hirschsprung Disease

    Jun 1, 2023, 00:00

  • CO201 Persistency on Conventional Synthetic DMARDS without Evidence of Rheumatoid Arthritis Control; Identifying Populations That May Benefit from Availability of Lower-Cost TNFi Biosimilars

    Jun 1, 2023, 00:00

  • EPH113 Healthcare Utilization Remains Elevated Among People Living with Post-COVID-19 Condition More Than One Year after Acute COVID-19 Illness

    Jun 1, 2023, 00:00

  • OP11 The Influence of Extracurricular Activities on Radiology Resident Selection Decisions

    Jun 1, 2023, 00:00

  • EE317 Examining ICER's Inclusion of Novel Value Factors: Do They Move the Needle on Value Appraisals?

    Jun 1, 2023, 00:00

  • EPH43 Potential Association of Remdesivir and Hyperkalemia: A Disproportionality Analysis in USFDA Adverse Event Reporting System Database

    Jun 1, 2023, 00:00

  • CO207 Post-Operative ICU Admission and SOFA Score Assessment after Elective Surgery: A Comparative Case Study of Laparoscopic and Robot-Assisted Low Anterior Resection

    Jun 1, 2023, 00:00

  • EE541 Health Equity Improvements Driven By Faricimab for the Treatment of Diabetic Macular Edema in an Aggregate Distributional Cost-Effectiveness Analysis from an English NHS Perspective

    Jun 1, 2023, 00:00

  • RWD112 The Medication Regimen Complexity Index Score As an Indicator of Racial Health Disparities in Clinical Outcomes

    Jun 1, 2023, 00:00

  • PCR96 Benefits of ePRO Measurements (EPROM) in Clinical Trials and Implications from HTA Perspective

    Jun 1, 2023, 00:00

  • HTA73 Variability in Time to Decision (TTD) Among NICE and Cadth Health Technology Assessments (HTAs)

    Jun 1, 2023, 00:00

  • EE473 Cost-Effectiveness of Long-Acting Cabotegravir Plus Long-Acting Rilpivirine for the Treatment of HIV-1 in Taiwan

    Jun 1, 2023, 00:00

  • PCR22 Treatment Preferences Among Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the United States

    Jun 1, 2023, 00:00

  • EE519 Effect of Surgical Choices on the Cost of Breast Cancer Care

    Jun 1, 2023, 00:00

  • MT3 Delphi Panel on the Recommended Use of the Cue COVID-19 at Home Diagnostic Test

    Jun 1, 2023, 00:00

  • EPH9 Characterization of Demographics and Concomittant Symptoms in Patients with Post COVID-19 Conditions or Long COVID

    Jun 1, 2023, 00:00

  • EE140 The Long-Term Costs and Health Impacts of Huntington’s Disease: A Novel Health Economic Modeling Framework

    Jun 1, 2023, 00:00

  • HPR155 The Impact of the CVS-Aetna Merger on Aetna Enrollees’ Access to Specialty Drugs

    Jun 1, 2023, 00:00

  • PCR174 Characterizing Progressive Disease Burden amid Heterogeneity: Data Visualizations for Ambulatory Motor Function in Duchenne Muscular Dystrophy (DMD)

    Jun 1, 2023, 00:00

  • CO95 Blood Pressure Control and Discontinuation of Antihypertensive Therapy Among Patients with Hypertension Who Initiated Sodium-Glucose Cotransporter-2 Inhibitors

    Jun 1, 2023, 00:00

  • MSR55 Identifying Treatment Patterns for Diffuse Large B-Cell Lymphoma in Real-World Data Using Unsupervised Machine Learning

    Jun 1, 2023, 00:00

  • EE288 The Healthcare Resource Utilisation Associated with Managing Fragile X Syndrome

    Jun 1, 2023, 00:00

  • EE123 Cost Evaluation of COVID-19 Remote Home Monitoring Services' Patients in England during Wave 2 from October 2020-April 2021

    Jun 1, 2023, 00:00

  • CO14 Disparities in COVID-19 Related Outcomes in the United States By Race and Ethnicity: An Umbrella Review of Meta-Analyses

    Jun 1, 2023, 00:00

  • PCR24 Measuring the Prevalence of Fatigue in Children with Cancer: Evidence from Egypt

    Jun 1, 2023, 00:00

  • MSR76 Prediction of High End-of-Life Costs Among Adults with Cancer Using a Machine Learning Approach

    Jun 1, 2023, 00:00

  • EPH85 A Cross- Sectional Assessment of Impact of COVID-19 Vaccine on Menstrual Cycle of Pharmacy and Medical Students of Qassim University, Saudi Arabia

    Jun 1, 2023, 00:00

  • CO125 Efficacy of Clascoterone Cream 1% for up to 12 Months in Patients ≥9 Years of Age with Acne vulgaris: Results from a Long-Term Extension Study

    Jun 1, 2023, 00:00

  • CO150 Risk Factors for Therapeutic Failure to Vancomycin in Adults with Methicillin-Resistant Staphylococcus Aureus Infection Treated in a Hospital in Cali, Colombia

    Jun 1, 2023, 00:00

  • CO229 Differences in 5-Year Weight Loss By Race and Insurance Payer Type in Patients Who Undergo Bariatric Surgery

    Jun 1, 2023, 00:00

  • PCR248 “Global” Problems in PGI Measures: The Patients’ Perspective on and Solutions to Poor PRO Word Choice

    Jun 1, 2023, 00:00

  • PCR120 Association of Race/Ethnicity and Patient Care Experiences with Receipt of Definitive Treatment Among Prostate Cancer Survivors: A SEER-CAHPS Study

    Jun 1, 2023, 00:00

  • EE304 Induction Cost per Responder of Biologic Therapies for Plaque Psoriasis in Canada

    Jun 1, 2023, 00:00

  • HTA72 Predicting Future ICER Value Assessments: A Neural Network Approach

    Jun 1, 2023, 00:00

  • EE325 The Cost of Reusable Cystoscopy in the US: A Systematic Review

    Jun 1, 2023, 00:00

  • PCR99 Regular COVID-19 Booster Shot Preference and Willingness to Pay in the Vietnamese Population: A Theory-Driven Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • EPH158 Assessment of the Effectiveness of Primary Health Care By Health Care Managers

    Jun 1, 2023, 00:00

  • PCR78 Real-World Pain Symptom Trajectory Among Multiple Myeloma Patients Under Remote Symptom Monitoring with Electronic Patient-Reported Outcomes (ePRO)

    Jun 1, 2023, 00:00

  • HSD102 The Role of Fall Risk-Increasing Drugs in Recent History of Falls Among Older Adult Cancer Survivors

    Jun 1, 2023, 00:00

  • HTA41 Surrogate Endpoints in Oncology: A Review of Recent Health Technology Appraisals in the United Kingdom

    Jun 1, 2023, 00:00

  • PCR44 The Impact of Health Literacy on Health-Related Quality of Life: A Cross-Sectional Study in Hong Kong

    Jun 1, 2023, 00:00

  • EE27 A Novel Cost Impact Analysis Framework and Model to Evaluate Medications for Opioid Use Disorder within the US Criminal Justice System

    Jun 1, 2023, 00:00

  • MSR16 Patient Survey Completion By Touchpoints in a Mailed Survey Methodology

    Jun 1, 2023, 00:00

  • CO203 Cumulative Anticholinergic Burden and Its Predictors Among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors

    Jun 1, 2023, 00:00

  • PCR101 Coverage of Aspects of Occupational Functioning By Health State Utility Instruments

    Jun 1, 2023, 00:00

  • Machine Learning in Outcomes Research

    Jun 1, 2023, 00:00

  • EE525 Topical Sirolimus 0.2% Gel for Facial Angiofibroma Associated with Tuberous Sclerosis Complex in the United States: A Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • EPH140 Safety of PDE-5 Inhibitors for Erectile Dysfunction: Descriptive and Disproportionality Analyses of the FDA Adverse Event Reporting System (FAERS) Database from 2010 to 2022

    Jun 1, 2023, 00:00

  • EE214 Unravelling the Elements of Value of Health Care and Assessing Their Importance Using Evidence from Two Discrete-Choice Experiments in England

    Jun 1, 2023, 00:00

  • PCR206 Effectiveness and Cost-Effectiveness of a Comprehensive Package Based on Electronic Medication Monitors at Improving Treatment Outcomes Among Tuberculosis Patients in Tibet: A Multi-Centre Randomised Controlled Trial

    Jun 1, 2023, 00:00

  • P59 Medication Adherence and Subsequent Year Payer Medical Costs Among Medicare Advantage Beneficiaries: Differences across Quality Measures

    Jun 1, 2023, 00:00

  • EE96 Budget Impact Analysis of Pneumococcal Vaccines for Older Adults Available in Costa Rica

    Jun 1, 2023, 00:00

  • HPR52 Pre-Approval Information Exchange (PIE) in the US. Sharing the Pie

    Jun 1, 2023, 00:00

  • HSD100 Exploring the Path to Diagnosis for Patients with Myasthenia Gravis Using Real-World Data

    Jun 1, 2023, 00:00

  • CO198 Anatomical Characterization of Long Bone Femur and Tibial Fractures and Associated Two-Year Risks of Non-Union – A US Database Analysis

    Jun 1, 2023, 00:00

  • CO154 Are Biosimilars Equivalent to Originator Molecules in the Real-World? Assessments of Efficacy, Toxicity, and Tolerability of Infliximabs in Infliximab-Naïve Patients with Rheumatoid Arthritis

    Jun 1, 2023, 00:00

  • EE313 Utilisation of the Cost-Saving Impact of Biosimilar Switching in Ophthalmological Diseases in the NHS: A Case-Study for a Ranibizumab Biosimilar

    Jun 1, 2023, 00:00

  • CO20 Predictors of Sustainability of Response with Cenobamate: Post-Hoc Subset Analysis of a Phase 3, Open-Label Study

    Jun 1, 2023, 00:00

  • EE511 Modeling Approaches in the Cost-Effectiveness Analysis of Cancer Treatments: A Review of Submissions Made to the Canadian Agency for Drugs and Technologies in Health

    Jun 1, 2023, 00:00

  • EPH69 Economic Impact of Clozapine Treatment Persisten A Canadian Perspective

    Jun 1, 2023, 00:00

  • EE405 A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

    Jun 1, 2023, 00:00

  • EE241 Economic Burden of Influenza Hospitalization in High-Risk Patient Groups in the US

    Jun 1, 2023, 00:00

  • MSR50 A Practical Method for Determining the Optimal Allocation between Computation Time and Accuracy in Probabilistic Patient-Level Microsimulation Models

    Jun 1, 2023, 00:00

  • RWD143 Lift Off: From Real World Data Quality Guidelines to Actionable Assessment

    Jun 1, 2023, 00:00

  • PCR246 Patient Perspectives on Non-Medical Switching

    Jun 1, 2023, 00:00

  • EPH135 Evaluation of Demographic Data of Inflammatory Breast Cancer Disease in a Cohort of Mexican Women from a Public Health Institution

    Jun 1, 2023, 00:00

  • EE197 Cost-Effectiveness of Monoclonal Antibodies (MABs) for Rheumatoid Arthritis (RA) in the United States

    Jun 1, 2023, 00:00

  • P42 Value-Based Pricing for Drugs with Accelerated Approval Incorporating Uncertainty and Risk Aversion

    Jun 1, 2023, 00:00

  • CO211 Real-World Treatment Patterns of Early-Stage Hepatocellular Carcinoma (HCC) after Complete Resection or Ablative Therapy: Retrospective, Medical Chart Review in the United States

    Jun 1, 2023, 00:00

  • Eliciting Trade-Offs Between Equity and Efficiency: A Methodological Scoping Review [Editor's Choice]

    Jun 1, 2023, 00:00

  • HPR114 Formulary Management of Biologics in Plaque Psoriasis in Canada

    Jun 1, 2023, 00:00

  • EE153 Cost-Effectiveness of First-Line Nivolumab Combination Therapy Vs Chemotherapy Alone for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Jun 1, 2023, 00:00

  • HTA40 Living Network Meta-Analysis for up-to-Date Comparative Effectiveness: A Case Study in Metastatic Castration Resistant Prostate Cancer (MCRPC)

    Jun 1, 2023, 00:00

  • PCR185 Psoriasis-Related Work Productivity Improvement from a Phase 4 Real-World Study of Tildrakizumab in Patients with Moderate to Severe Plaque Psoriasis

    Jun 1, 2023, 00:00

  • OP7 Potential Net Promoter Score (NPS) Factor Analysis Anomaly Prediction in Context of Healthcare

    Jun 1, 2023, 00:00

  • P60 Cost-Related Medical Care Use Reduction and Mediation Nonadherence in US Adults with Multiple Chronic Conditions: A Comparison of High Deductible Health Plans and Traditional Insurance Enrollees

    Jun 1, 2023, 00:00

  • CO44 Scoping Review and Meta-Analysis on the Effectiveness and Safety of Powered Stapler and Manual Stapler

    Jun 1, 2023, 00:00

  • PCR136 A Retrospective Analysis of Real-World Treatment Patterns in Patients over Age 64 with Dry Eye Disease Receiving OTX-101 Ophthalmic Solution 0.09%, Cyclosporine Ophthalmic Emulsion 0.05%, or Lifitegrast Ophthalmic Solution 5%

    Jun 1, 2023, 00:00

  • CO192 Primary Cardiovascular Event Risk Associated with Nonalcoholic Steatohepatitis Among US Adults, NHANES 2017-2020

    Jun 1, 2023, 00:00

  • EE176 A Cost Analysis on Complications of Fabry Disease Patients Treated with Agalsidase Alfa and Agalsidase Beta in Colombia

    Jun 1, 2023, 00:00

  • HTA45 Value-Based Price Forecasting: An Accurate Method for Orphan Drugs?

    Jun 1, 2023, 00:00

  • SA45 Dealing with Uncertainty in Cost-Effectiveness and Affordability to Inform Risk-Averse Healthcare Decision Makers

    Jun 1, 2023, 00:00

  • EE219 Cost-Effectiveness of Dapagliflozin Vs. Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction

    Jun 1, 2023, 00:00

  • HTA64 Burden of Illness in Patients with Facial Angiofibroma Associated with Tuberous Sclerosis Complex: A Systematic Review

    Jun 1, 2023, 00:00

  • EE215 Effect and Economic Evaluations of Pharmaceutical Care in China: A Systematic Review

    Jun 1, 2023, 00:00

  • EE555 Cost-Effectiveness of Etranacogene Dezaparvovec for the Treatment of Hemophilia B

    Jun 1, 2023, 00:00

  • EE7 The Importance of Considering Price Metrics and Market Dynamics in US Economic Evaluations: The Case of Sglt-2 Inhibitors in the Treatment of Type 2 Diabetes (T2D)

    Jun 1, 2023, 00:00

  • HPR142 The Impact of Neighborhood Factors on Pediatric Ed Visits for Ambulatory Care Sensitive Conditions

    Jun 1, 2023, 00:00

  • EE278 A Systematic Review of Economic Evaluations of Cervical Cancer Screening Methods

    Jun 1, 2023, 00:00

  • RWD44 Use of Real-World Data for Hard-to-Identify Patient Population: Methodology and a Case Study

    Jun 1, 2023, 00:00

  • CO200 Early Remission Is Associated with Lower Risk of Relapse: Analysis of Major Depressive Disorder Using STAR*D

    Jun 1, 2023, 00:00

  • EE314 Analysis of Factors Influencing Originator Market Share Following Biosimilar Competition

    Jun 1, 2023, 00:00

  • EE308 Estimated Annual Costs Among Patients with Activated PI3K Delta Syndrome

    Jun 1, 2023, 00:00

  • EPH106 Prevalence and Patient Characteristics of Valvular Heart Disease in Heart Failure Hospitalization in Japan: Real-World Claims Data Analysis

    Jun 1, 2023, 00:00

  • P19 Using AI to Support Evidence Market Access Strategy Development

    Jun 1, 2023, 00:00

  • EE388 Marginal Health Care Expenditures Burden for Breast Cancer Patients: A Medical Expenditure Panel Survey Study

    Jun 1, 2023, 00:00

  • EE330 A Cost Analysis for Major Cardiovascular Events in Influenza Vaccinated and Unvaccinated Patients after Myocardial Infarction in Colombia

    Jun 1, 2023, 00:00

  • HPR71 Variations in Medicare Advantage Prior Authorization Policies for High-Cost Oncology Immunotherapies

    Jun 1, 2023, 00:00

  • RWD174 Real World Treatment Usage of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs in US Patients with Psoriatic Arthritis: Persistence, Factors Associated with Non-Persistence, and Dosing Patterns

    Jun 1, 2023, 00:00

  • EPH207 Factors Associated with COVID-19 Infections and Deaths in the Gulf Cooperation Council (GCC) Countries: A Time Series Cross-Section Analysis

    Jun 1, 2023, 00:00

  • EPH94 Gender, Ethnic, and Racial Disparities Among Cell and Gene Therapy Clinical Trials

    Jun 1, 2023, 00:00

  • HSD33 Medical Costs, Hospitalizations, and Length of Stay Associated with Discontinuations in Cycled Oral Antineoplastics Among Medicare-Eligible Oncology Patients

    Jun 1, 2023, 00:00

  • HTA6 Balancing National Financial Stability with Commercial Expectations of Return on RD Investment: A Review of Price Discounts for the Reimbursement of Oncology Drugs in Brazil

    Jun 1, 2023, 00:00

  • HSD118 Improving Healthcare Deserts in Sub-Saharan Africa: A Health Improvement Pilot Study Leveraging a Global, Cloud-Based Telemedicine Platform

    Jun 1, 2023, 00:00

  • RWD16 Laparoscopic Surgery for Adrenocortical Carcinoma: Estimating the Risk of Margin-Positive Resection

    Jun 1, 2023, 00:00

  • MSR64 Psychometric Validation of the Electronic Hidradenitis Suppurativa Quality of Life (eHiSQOL) Questionnaire Using Pooled Data from the Phase 3 BE HEARD Trials of Bimekizumab in Hidradenitis Suppurativa

    Jun 1, 2023, 00:00

  • Disability-Adjusted Life-Years for Drug Overdose Crisis and COVID-19 Are Comparable During the Two Years of Pandemic in the United States

    Jun 1, 2023, 00:00

  • EE274 Is It Worthwhile for an Orphan Product to Expand Indications Given the Risk of Medicare Negotiation?

    Jun 1, 2023, 00:00

  • Economic Evaluations of Rare Diseases

    Jun 1, 2023, 00:00

  • MSR5 Distribution of the Annual Costs of a Cohort of Patients with Diabetes in a Large Colombian Health Insurer

    Jun 1, 2023, 00:00

  • CO115 Psychometric Evaluation of Customized Lymphoma-Specific Symptom Measures Using the EORTC QLQ-C30 and Item Library: Data from a Phase 1/2 Clinical Trial of Pirtobrutinib

    Jun 1, 2023, 00:00

  • EPH213 Understanding the Relationship between Socioeconomic Disadvantage Ranking and Access to Aortic Valve Procedures

    Jun 1, 2023, 00:00

  • PCR165 Translation and Cultural Adaptation of the Essential Tremor Embarrassment Assessment (ETEA) Questionnaire to the Romanian Population

    Jun 1, 2023, 00:00

  • EPH247 Pain and Arthralgia Adverse Events Associated with Crizanlizumab and Voxelotor: Disproportionality Analysis of US FDA Adverse Events Reporting System (FAERS)

    Jun 1, 2023, 00:00

  • EE148 Anxiety, Depression, Stress Reaction and Adjustment Disorders, and Their Associations with Healthcare Costs Among Newly Diagnosed Patients with Breast Cancer: A Retrospective Observational Cohort Study

    Jun 1, 2023, 00:00

  • EE361 Economic Evaluation of Screen-and-Treat Strategies for Asymptomatic Helicobacter Pylori Infection in China

    Jun 1, 2023, 00:00

  • HSD83 Hypertension and Pregnancy: Pharmacologic Treatment and Pregnancy Outcomes

    Jun 1, 2023, 00:00

  • EE152 Cost-Effectiveness Modeling of Lurbinectedin As a Second-Line Therapy in Patients with Small Cell Lung Cancer (SCLC)

    Jun 1, 2023, 00:00

  • EPH206 Opioid Overdose Mortality Association with Access to Medical Care

    Jun 1, 2023, 00:00

  • EE98 Health Economic Evaluation of COVID-19 Vaccines: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • EE107 Cost-Effectiveness of Mechanical Thrombectomy for Acute Ischemic Stroke: Colombian Health System Perspective

    Jun 1, 2023, 00:00

  • MSR56 A Supplementary Search to Identify Additional Relevant Literature Not Captured in a Systematic Literature Review Search Strategy

    Jun 1, 2023, 00:00

  • PCR107 A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Patient Reported Outcome Measures Part I: Instrument Development and Content Validity

    Jun 1, 2023, 00:00

  • HPR125 Descriptive Study Investigating Impact of Transition to Universal Health Insurance Coverage on Utilization of Healthcare in Sudan, 2016 - 2021

    Jun 1, 2023, 00:00

  • P18 A Review of HTA Guidelines on Societal and Novel Value Elements

    Jun 1, 2023, 00:00

  • SA29 “Cash or Credit?” Feedback from Patients on the Use of Reward Programs in Digital Research

    Jun 1, 2023, 00:00

  • PCR195 Developing a Framework to Capture Economic Impacts on Patients and Caregivers: Recommendations to Guide Patient-Centered Outcomes Research and Value Assessment

    Jun 1, 2023, 00:00

  • PCR188 Assessing Patient Preference for Verbal Descriptor Scales

    Jun 1, 2023, 00:00

  • P56 Comparison of Methods for Incorporating Time-to-Event Outcomes in Budget Impact Analyses

    Jun 1, 2023, 00:00

  • RWD148 A Comparative Evaluation of Medicare's Hospital Readmissions Reduction Program (HRRP) Effectiveness between New York State and the Nation

    Jun 1, 2023, 00:00

  • EE15 Cost-Effectiveness Evaluation of Human Papilloma Virus Test in Comparison with Cytology in Uruguay from the Public Health System Perspective

    Jun 1, 2023, 00:00

  • EE216 Which Modelling Methods Can Account for Additional Value Elements in HTAs? Results from a Pragmatic Review

    Jun 1, 2023, 00:00

  • EE97 Optimal Gonorrhea Control through Vaccination and Screening: A Mathematical Modeling and Cost-Effectiveness Study

    Jun 1, 2023, 00:00

  • RWD40 Standard Costing of Frequencies of Use of Services Related to Chronic Venous Disease Care in a Cohort of Patients from a Colombian Health Insurer

    Jun 1, 2023, 00:00

  • CO158 Relationship between Overall Response Rate (ORR), Progression-Free Survival (PFS), and Overall Survival (OS) in Clinical Trials of Patients with Mantle Cell Lymphoma (MCL)

    Jun 1, 2023, 00:00

  • EPH163 Association of Weight Loss Agents with the Risk of Abnormal Liver Function: A Population-Based Cross-Sectional Study

    Jun 1, 2023, 00:00

  • RWD102 Cluster Algorithm for Credible Subgroup Identification in Patients with Erectile Dysfunction Receiving Tadalafil: A Real-World Data Study

    Jun 1, 2023, 00:00

  • HSD115 Comparison of Primary Care Quality Among Rural, Urban, and Online Providers: Evidence from a Pooled Analysis of Standardized Patient Studies in China

    Jun 1, 2023, 00:00

  • HSD105 Sociodemographic Variations in PSA Screening Use: A Cross-Sectional Analysis of Data from the National Health Interview Survey

    Jun 1, 2023, 00:00

  • EE92 Economic Impact of Pencil Point Spinal Needles Versus Conventional Cutting Needles on Postdural Puncture Headache

    Jun 1, 2023, 00:00

  • MSR40 Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial Results

    Jun 1, 2023, 00:00

  • RWD145 Machine Learning and Artificial Intelligence for Clinical Trial Optimization: A Review of Opportunities to Leverage Real World Data

    Jun 1, 2023, 00:00

  • RWD27 Disparities in Incidence, Real World Treatment Patterns, and Medication Adherence Among Patients with Systemic Lupus Erythematosus (SLE) in the US: A Retrospective Claims and Electronic Health Records Analysis

    Jun 1, 2023, 00:00

  • EE276 Economic Evaluation of Trifluridine and Tipiracil Hydrochloride in the Treatment of Metastatic Gastric Cancer in the Brazilian Private Health Care Sector

    Jun 1, 2023, 00:00

  • RWD74 Up to New Limits: The Number of Petaflops Necessary for Realistic Health Economic Models

    Jun 1, 2023, 00:00

  • PCR220 Symptom Burden in Late-Stage Breast Cancer Patients Treated with CDK Inhibitors Using the PRO-CTCAE

    Jun 1, 2023, 00:00

  • HPR89 Trends in Remote Patient Monitoring Among Medicare Beneficiaries during COVID-19: A Comparative Interrupted Time Series Analysis

    Jun 1, 2023, 00:00

  • CO12 Evaluation of Hyponatremia Risk Among Geriatric Patients Exposed to Selective Serotonin Reuptake Inhibitors (SSRIS) and Thiazide Diuretics

    Jun 1, 2023, 00:00

  • MT36 Cancer Biomarkers from a Technological Perspective: Past, Present, or Future?

    Jun 1, 2023, 00:00

  • EE65 What Is the Wider Carer and Family Burden in Leber’s Hereditary Optic Neuropathy? a Mixed-Methods Study

    Jun 1, 2023, 00:00

  • Patient and Community Preferences for Decision Making in Health Care

    Jun 1, 2023, 00:00

  • MT24 Health Technologies Aimed at the Aging Population Are Not a Global Concern

    Jun 1, 2023, 00:00

  • PCR97 Comparison of Patient-Reported Outcomes and Conventional Clinical Measures in Hospital Quality Assessment for Knee Replacement Surgery

    Jun 1, 2023, 00:00

  • EE102 Fluctuation in Treatment Initiation: Increasing the Accuracy of Modeling Patient Entry in Budget Impact Analyses

    Jun 1, 2023, 00:00

  • EE529 Characterizing Attack-Related Health Utility in Hereditary Angioedema

    Jun 1, 2023, 00:00

  • SA12 Use of Living Systematic Reviews (LSRS) Beyond COVID-19

    Jun 1, 2023, 00:00

  • SA39 Targeted Literature Review of Economic Burden and Modelling Techniques for Duchenne Muscular Dystrophy

    Jun 1, 2023, 00:00

  • EE161 An Assessment of the Direct and Indirect Costs of Bladder Cancer Preceding and Following a Cystectomy: A Real-World Evidence Study

    Jun 1, 2023, 00:00

  • EPH34 Trends in Prescription Contraceptive Use Among US Commercially Insured Women, 2017 – 2021

    Jun 1, 2023, 00:00

  • HPR78 A Comparison of Orphan Drugs Approved By the FDA and EMA, 1995-2022

    Jun 1, 2023, 00:00

  • CO83 IV Iron Treatment Episodes Among US Patients with Iron Deficiency Anemia

    Jun 1, 2023, 00:00

  • EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission

    Jun 1, 2023, 00:00

  • RWD76 Using Real World Data to Quantify Risk Factors for Ischemic Stroke in Colombia

    Jun 1, 2023, 00:00

  • CO149 Prevalence of Chain-of-Event and Contributing Conditions Among Treated COVID-19 Patients in the United States: Identifying Risk Factors Associated with Deaths

    Jun 1, 2023, 00:00

  • P40 How Did FDA Consider Patient Experience Data in Regulatory Decisions Among Approved Drugs in 2022?

    Jun 1, 2023, 00:00

  • EE40 Identifying and Quantifying Elements of Value for Nivolumab and Ipilimumab in First-Line Non-Small Cell Lung Cancer

    Jun 1, 2023, 00:00

  • HPR111 A Systematic Review of Real-World Evidence (RWE) Supportive of New Drug and Biologic License Application Approvals in Rare Diseases

    Jun 1, 2023, 00:00

  • RWD98 Understanding the Role of Real-World Evidence for Reimbursement and Market Access of Ultra Orphan Drugs: Insights and Lessons from Case Studies of NICE Highly Specialized Technology (HST) Assessment Reports

    Jun 1, 2023, 00:00

  • EE510 Economic Modeling of Adjuvant or Neoadjuvant Therapies in Oncology – HTA Review of NICE Technology Appraisals, 2019-2022

    Jun 1, 2023, 00:00

  • EPH95 Evaluation of Adverse Drug Reactions and Quality of Life of HIV Patients Assessing Care at Public Secondary Hospitals in Ilorin, Nigeria

    Jun 1, 2023, 00:00

  • EE516 Health Economic Evaluation of Hepatocellular Carcinoma Screening and Optimized Whole Course Management Strategies in China

    Jun 1, 2023, 00:00

  • PCR16 Patient-Reported Outcomes in Opioid Use Disorder (PR-OUD): Recommendations and Barriers in Clinical Trials and Studies

    Jun 1, 2023, 00:00

  • CO19 Relative Efficacy of Pharmacological Treatments of Agitation and Aggression in Patients with Dementia: A Systematic Review and Network Meta-Analysis

    Jun 1, 2023, 00:00

  • RWD166 Comparative Real-World Retrospective Data Analysis of Comorbid Conditions and Healthcare Utilization for Patients with Myotonic Dystrophy over a 5-Year Timeframe

    Jun 1, 2023, 00:00

  • HSD7 Prescribing Behavior Among Community Oncologists for Generics/Biosimilars While Considering Costs or Financial Toxicity When Treating Cancer

    Jun 1, 2023, 00:00

  • HPR49 The Inflation Reduction Act Exclusion Effect: An Analysis of Inflation Reduction Act Minimum-Discount Negotiation Rules

    Jun 1, 2023, 00:00

  • EE267 Racial Disparity in Total Annual Healthcare Expenditure for Cervical Cancer Patients: A 6 Years (2014-2019) US National Study

    Jun 1, 2023, 00:00

  • PCR145 A Qualitative Exploratory Study on Developing and Selecting Potential Bolt-on for the EQ-5D Hong Kong Sar, China

    Jun 1, 2023, 00:00

  • PCR2 The Magnitude of the Association between Insulin Adherence Based on Prescription Fill Rate Measures and Glycemic Control: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • EE282 Financial Burden of Progression of Chronic Myeloid Leukemia (CML) Patients Who Failed Two or More Tyrosine Kinase Inhibitors Treatment in the Brazilian Private Market Perspective

    Jun 1, 2023, 00:00

  • EE249 Healthcare Resource Utilization with Adjunctive Cariprazine and Other Atypical Antipsychotics in Patients with Major Depressive Disorder

    Jun 1, 2023, 00:00

  • EE52 Cost-Effectiveness Analysis of Crizotinib Versus Chemoterapy for First Line Treatment of Non-Small Cell Lung Cancer Alk+, from the Brazilian Public Healthcare System Perspective

    Jun 1, 2023, 00:00

  • PCR32 Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

    Jun 1, 2023, 00:00

  • HPR91 The State of Cost-Effectiveness Analyses on Health Services and Procedures

    Jun 1, 2023, 00:00

  • PCR50 The Development of a Valid Qualitative Standardized Interview Manual

    Jun 1, 2023, 00:00

  • EE223 Impact of Inclusion of Vericiguat in the Burden of Disease of Heart Failure with Reduced Ejection Fraction (HFREF) and Worsening HF Event in Colombia

    Jun 1, 2023, 00:00

  • EE327 Unfavorable Outcomes Associated with Genetic Screening of HLA-B*13:01 for the Prevention of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Among HIV-Infected Patients in Thailand: A Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • EE260 Cost-Effectiveness Analysis of Sacituzumab Govitecan As Second-Line Treatment for Metastatic Triple-Negative Breast Cancer in Japan

    Jun 1, 2023, 00:00

  • EE156 Budget Impact Analysis of Inotuzumab Ozogamicin for the Treatment of Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia in Colombia

    Jun 1, 2023, 00:00

  • PCR125 Development of a Pediatric Version of the Study Medication Withdrawal Questionnaire (SMWQ)

    Jun 1, 2023, 00:00

  • PCR243 Exploring Health Outcomes By Occupation: Using the National Health and Wellness Survey to Describe Differences in Self-Reported Occupation Profiles

    Jun 1, 2023, 00:00

  • EE122 The Economic Impact of a Psychosocial Utility Benefit Associated with Pre-Exposure Prophylaxis (PrEP) for COVID-19, in Immunocompromised (IC) Individuals – a Case Study for Future PrEP Evaluations

    Jun 1, 2023, 00:00

  • PCR133 Somatotrophin Treatment Patterns: Real-World Data from Argentina

    Jun 1, 2023, 00:00

  • EE81 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab (NIVO+IPI) Versus Pembrolizumab Plus Axitinib (PEM+AXI) for the First-Line Treatment of Intermediate- and Poor (I/P)-Risk Advanced Renal Cell Carcinoma Patients in Colombia

    Jun 1, 2023, 00:00

  • EE297 Impact of Breathlessness Severity on Quality of Life, Healthcare Use, Productivity Loss and Economic Cost to the Australian Society

    Jun 1, 2023, 00:00

  • PCR159 The Clinical and Financial Impact of Blue Cross and Blue Shield of Louisiana Waiving Cost Share for the First Mental Health and Substance Use Disorder Follow-up Visit

    Jun 1, 2023, 00:00

  • P32 Psychometric Evaluation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Core 30-Items and Myeloma 20-Item Module in Multiple Myeloma Patients

    Jun 1, 2023, 00:00

  • P44 Moral Hazard Effects of Payment Methods Reform in China

    Jun 1, 2023, 00:00

  • PCR74 Trends in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials: Analysis of ClinicalTrials.gov (2013-2022)

    Jun 1, 2023, 00:00

  • EE99 Cost-Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in the Immunization of Children Under Five Years for the Prevention of Invasive Pneumococcal Disease and Pneumonia in the Brazilian Public Healthcare System

    Jun 1, 2023, 00:00

  • SA62 Prescribing Patterns and Preference Attributes of Novel Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism in Real-World Practice in China: A Nationwide Physician Survey

    Jun 1, 2023, 00:00

  • EE63 Cost-Hemophilia Brazil

    Jun 1, 2023, 00:00

  • EE500 Cost-Effectiveness Analysis of Cemiplimab As Second-Line Therapy for Recurrent Cervical Cancer in Japan

    Jun 1, 2023, 00:00

  • EPH221 Persons Diagnosed with COVID-19 in the Clinical Practice Research Datalink (CPRD) Primary Care Dataset: A Cohort Description

    Jun 1, 2023, 00:00

  • RWD26 Variation in Demographic Characteristics, Socioeconomic Status, Clinical Presentation and Selected Treatments in Mortality Among Patients with a Diagnosis of COVID-19 in the United States

    Jun 1, 2023, 00:00

  • EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments

    Jun 1, 2023, 00:00

  • EE184 Economic Burden of Cystic Fibrosis in the United States: A Systematic Review

    Jun 1, 2023, 00:00

  • EE574 Innovative Mechanisms of Pre-Market Authorization Access for Rare Diseases in Brazil. a Case Study of Pabinafusp-Alfa for Mucopolysaccharidosis Type II

    Jun 1, 2023, 00:00

  • CO68 Simulated mOS of Gemcitabine+Carboplatin ± Maintenance Avelumab Therapy or Enfortumab Vedotin + Pembrolizumab in First-Line Treatment of LA/mUC in Patients Ineligible for Cisplatin Using Disease Modeling

    Jun 1, 2023, 00:00

  • HPR106 Identifying Value Drivers for a Novel Treatment Targeting Core Symptoms of Autism Spectrum Disorder

    Jun 1, 2023, 00:00

  • EPH181 An Analysis of Patient Characteristics Associated with Myelosuppression Among Small Cell Lung Cancer (SCLC) Patients Treated in US Community Cancer Care Practices

    Jun 1, 2023, 00:00

  • EE572 Intersection of Machine Learning and HEOR: A Systematic Review

    Jun 1, 2023, 00:00

  • EE375 Work and Activity Impairment in Huntington Disease

    Jun 1, 2023, 00:00

  • P3 Cost Effectiveness of Newborn Genetic Screening for Long QT Syndrome

    Jun 1, 2023, 00:00

  • CO165 Comparison of Non-Robotic Surgery Vs. Robot-Assisted Surgery for Radical Prostatectomy

    Jun 1, 2023, 00:00

  • HPR13 Medicare Part B Spending on Biologics Due to Inadequate Biosimilar Uptake

    Jun 1, 2023, 00:00

  • SA55 Considerations for Common Exclusion Criteria in Real-World (RW) Retrospective Observational Studies in Oncology

    Jun 1, 2023, 00:00

  • EE298 Cost-Effectiveness of E-Cigarettes for Smoking Cessation Among Medicaid Users

    Jun 1, 2023, 00:00

  • HPR57 Evidence Demonstration Framework for Medicare Part B and D Products Subject to Inflation Reduction Act (IRA) Price Regulations

    Jun 1, 2023, 00:00

  • EE463 Direct Medical Costs of Diabetes Mellitus in Colombia

    Jun 1, 2023, 00:00

  • HSD50 Landscape and Management Strategies of Obesity in Older Adults Enrolled in Humana Medicare Advantage Plans

    Jun 1, 2023, 00:00

  • EPH33 The Female-to-Male Surgical Sterilization Ratio As Another Indicator of the Gender-Equity Gap

    Jun 1, 2023, 00:00

  • PCR30 The Burden of Familial Chylomicronemia Syndrome (FCS) in Brazilian Patients – A Pilot Qualitative Study

    Jun 1, 2023, 00:00

  • MT16 Efficiency and User Satisfaction of Single-Use Vs Reusable Cystoscopes in a High-Volume Urology Clinic

    Jun 1, 2023, 00:00

  • CO169 A Mixed Methods Approach to Characterize the Global Prevalence of Glycogen Storage Disease Type III and Associated Disease Complications

    Jun 1, 2023, 00:00

  • RWD13 Representation of Sex at Birth in Real-World Evidence, Randomized Clinical Trial, and Surveillance, Epidemiology, and End Results (SEER) Cancer Patient Registry Data By Cancer Type

    Jun 1, 2023, 00:00

  • PCR132 Symptoms and Impacts of Transfusion-Dependent Beta-Thalassemia: A Qualitative Interview Study and the Development of a Conceptual Model

    Jun 1, 2023, 00:00

  • CO136 Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged 6 and Older with Mild to Moderate Atopic Dermatitis in Two Phase 3 Integument Trials

    Jun 1, 2023, 00:00

  • HPR85 Determining the Pricing Checkpoints over an Originator's Lifecycle in China

    Jun 1, 2023, 00:00

  • EPH15 Increased Risk of Adverse Events Following Burn Injury in Patients with Hypothyroidism

    Jun 1, 2023, 00:00

  • CO204 Primary and Secondary Endpoints Used in Recent (2022) Alzheimer’s Disease (AD) Phase III Clinical Trials

    Jun 1, 2023, 00:00

  • HPR67 Ejadah: Implementation of Value-Based Healthcare in Emirate of Dubai

    Jun 1, 2023, 00:00

  • EE279 Real-World Evidence Relating Cytopenia Diagnosis to Hospitalization and Cost of Care in the Treatment of Non-Small Cell Lung Cancer Patients

    Jun 1, 2023, 00:00

  • EE251 Drug Expenditure, Price, and Utilization in the U.S. Medicaid Program: An Empirical Trend Analysis for Nonbiologic and Biologic DMARDS

    Jun 1, 2023, 00:00

  • CO209 Association between Baseline Bone Mineral Density Testing and the Risk of Fractures in Men Initiating Androgen Deprivation Therapy: Population-Based Study

    Jun 1, 2023, 00:00

  • EE4 Hospital Resource Use in below-Knee Surgical Bypass Procedures with Eptfe Vascular Grafts with Heparin End-Point Covalent Bond in Critical Limb Ischemia Peripheral Arterial Disease (PAD) Patients

    Jun 1, 2023, 00:00

  • Decisions and Deliberative Processes in Health Technology Assessment

    Jun 1, 2023, 00:00

  • RWD132 A Real-World Evidence Study on the Chronic Obstructive Pulmonary Disease Treatments Submitted to the Brazilian National Committee for Health Technology Incorporation

    Jun 1, 2023, 00:00

  • RWD77 $0 Drug Copay Program Increases Generic Drug Use Among Members with Diabetes in Louisiana: Six-Month Outcomes Analysis

    Jun 1, 2023, 00:00

  • EE412 Analyzing the Financial Impact of a Remote Fetal Monitoring Solution Introduction for High-Risk Pregnancies in a US Obstetrics Clinic

    Jun 1, 2023, 00:00

  • EPH190 Cluster Analysis on RWD to Find Patterns of Multimorbidity: A Conceptual Framework

    Jun 1, 2023, 00:00

  • EE341 Cost Effectiveness of Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia in Mexico

    Jun 1, 2023, 00:00

  • PCR173 Predictors of Pediatric Emergency Department (ED) Visits for the Acute Ambulatory Care Sensitive Conditions (ACSC)

    Jun 1, 2023, 00:00

  • EE194 Marginal Healthcare Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Chronic Kidney Disease: 2011-2020

    Jun 1, 2023, 00:00

  • RWD127 Mapping the Flow of Biomarker Testing Information, from Test Order through Impact on Treatment Decision-Making: A Case Study in Metastatic NSCLC

    Jun 1, 2023, 00:00

  • EPH70 Trends in Hospitalizations Related to Anxiety, Depression, and/or Substance Use Among Adult Inpatients from 2016-2020 in the United States

    Jun 1, 2023, 00:00

  • HSD62 An Analysis of Asthma Care Pathways and Patient Outcomes in an East London Population Cohort: A Longitudinal Analysis Using Routinely Collected Data

    Jun 1, 2023, 00:00

  • EE189 Cost-Effectiveness Analysis of Dupilumab in Severe Atopic Dermatitis Patients Aged >= 6 Years Old Who Have Failed to Topical Therapies or When Those Therapies Are Not Recommended

    Jun 1, 2023, 00:00

  • HSD75 What Features of Telehealth Are Important to Patients in HIV Care? A Systematic Literature Review

    Jun 1, 2023, 00:00

  • EE374 Expected Cost of an FDA-Authorized Prescription Digital Therapy for Children with ADHD

    Jun 1, 2023, 00:00

  • RWD180 What Does Healthcare Resource Utilization Look like in the General Population of the US? A Real-World Analysis Using Claims Data

    Jun 1, 2023, 00:00

  • HTA12 Key Features and Challenges of Cell and Gene Therapies Highlighted in Health Technology Assessment (HTA) Submissions

    Jun 1, 2023, 00:00

  • EE238 Clinical and Economic Burden of Invasive Escherichia coli Disease Among Commercially Insured Adult Patients in the United States

    Jun 1, 2023, 00:00

  • EPH5 Validity and Accuracy of Weight Status-Related Diagnosis Codes Among Hospitalized Patients in the United States: 2017−2021

    Jun 1, 2023, 00:00
  • «
  • 21
  • 22
  • 23
  • 24 (current)
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • »